Home
Ishita Drugs & Industries Ltd Quarterly Result

Ishita Drugs & Industries Ltd
NSE: ISHITADRUGS
Net Profit - Last Quarter
Ishita Drugs & Industries Ltd Quarterly Results Key Highlights
- The revenue of Ishita Drugs & Industries Ltd for the Mar '25 is ₹ 4.72 crore as compare to the Dec '24 revenue of ₹ 4.2 crore.
- This represent the growth of 12.38%a1# The ebitda of Ishita Drugs & Industries Ltd for the Mar '25 is ₹ 0.45 crore as compare to the Dec '24 ebitda of ₹ 0.36 crore.
- This represent the growth of 25%a1# The net profit of Ishita Drugs & Industries Ltd for the Mar '25 is ₹ 0.29 crore as compare to the Dec '24 net profit of ₹ 0.24 crore.
- This represent the growth of 20.83%a1#.
Ishita Drugs & Industries Ltd Quarterly Results Analysis
Market Price of Ishita Drugs & Industries Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
18 Jul 2025 | 79.83 |
17 Jul 2025 | 76.99 |
16 Jul 2025 | 75.98 |
15 Jul 2025 | 76 |
14 Jul 2025 | 76 |
11 Jul 2025 | 76.03 |
10 Jul 2025 | 77.27 |
09 Jul 2025 | 79.45 |
08 Jul 2025 | 79.22 |
07 Jul 2025 | 81.6 |
Historical Revenue of Ishita Drugs & Industries Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Ishita Drugs & Industries Ltd
Historical EBITDA of Ishita Drugs & Industries Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Ishita Drugs & Industries Ltd
Historical Net Profit of Ishita Drugs & Industries Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Ishita Drugs & Industries Ltd
Ishita Drugs & Industries Ltd News Hub
Ishita Drugs & Industries standalone net profit rises 7.14% in the June 2024 quarter
Net profit of Ishita Drugs & Industries rose 7.14% to Rs 0.15 crore in the quarter ended June 2024 a
Read more
14 Aug 24
Ishita Drugs & Industries to declare Quarterly Result
Ishita Drugs & Industries will hold a meeting of the Board of Directors of the Company on 13 August
Read more
10 Aug 24
Ishita Drugs & Industries AGM scheduled
Ishita Drugs & Industries announced that the Annual General Meeting (AGM) of the company will be hel
Read more
28 Aug 24
Ishita Drugs & Industries standalone net profit declines 9.52% in the September 2024 quarter
Net profit of Ishita Drugs & Industries declined 9.52% to Rs 0.19 crore in the quarter ended Septemb
Read more
13 Nov 24